Zacks Investment Research on MSN
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...
Pfizer Inc. (NYSE:PFE) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Pfizer Inc. (NYSE:PFE) ...
Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...
Pfizer CEO Albert Bourla, who was in the Oval Office with the president for the announcement, said Mr. Trump's threat of 100% ...
The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.
One Louisiana woman, Robin Phillip, said she developed an intracranial meningioma that caused her to lose vision in her left ...
Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...
Pfizer made a deal with the administration to implement President Donald Trump's Most Favored Nation drug pricing policies.
President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also unveiling a TrumpRx website.
Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...
The deal is part of Trump's broader effort to tie the amount the government pays for certain drugs to the prices paid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results